GFA
ANGO icon

Gallagher Fiduciary Advisors’s AngioDynamics ANGO Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Sell
45,248
-584
-1% -$6.65K 0.02% 166
2026
Q1 		$521K Buy
45,832
+933
+2% +$10.1K 0.02% 153
2025
Q4 		$577K Buy
44,899
+4,067
+10% +$50.2K 0.02% 159
2025
Q3 		$456K Buy
+40,832
New +$394K 0.02% 180

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gallagher Fiduciary Advisors's ANGO Position: Q2 2026 in Review

Gallagher Fiduciary Advisors reduced its AngioDynamics (ANGO) stake by 1.3% in Q2 2026, selling an estimated $6.65K and leaving 45,248 shares worth $589K. The position accounts for 0.02% of the portfolio, ranked #166.

Gallagher Fiduciary Advisors first reported a position in ANGO in Q3 2025 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Gallagher Fiduciary Advisors held 45,248 shares of AngioDynamics worth $589K as of Q2 2026.
  • Gallagher Fiduciary Advisors sold 584 AngioDynamics shares in Q2 2026, an estimated $6.65K.
  • AngioDynamics made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #166 holding.
  • Gallagher Fiduciary Advisors first reported a position in AngioDynamics in Q3 2025 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.